2.
肺癌组织中IL-8、MMP-9免疫组化表达水平与临床病理特征的关系
The relationship between tissue IL-8 and MMP-9 expressions and the clinicopathological characteristics
| Variables | n | IL-8 status | P | MMP-9 status | P | ||
| Positive | Negative | Positive | Negative | ||||
| Group | < 0.001 | < 0.001 | |||||
| Normal lung tissue | 25 | 2 | 23 | 3 | 22 | ||
| Benign lung tissue | 21 | 4 | 17 | 6 | 15 | ||
| Lung cancer tissue | 95 | 60 | 35 | 62 | 33 | ||
| Pathologic stage | 0.002 | 0.022 | |||||
| Stage Ⅰ | 38 | 18 | 20 | 20 | 18 | ||
| Stage Ⅱ | 19 | 10 | 9 | 11 | 8 | ||
| Stage Ⅲ, Ⅳ | 38 | 32 | 6 | 31 | 7 | ||
| Tumor status | 0.504 | 0.071 | |||||
| T1 | 17 | 9 | 8 | 7 | 10 | ||
| T2 | 54 | 24 | 20 | 38 | 16 | ||
| T3, T4 | 24 | 17 | 7 | 17 | 7 | ||
| Lymph node status | 0.008 | 0.022 | |||||
| N0 | 51 | 26 | 25 | 28 | 23 | ||
| N1, N2, N3 | 44 | 34 | 10 | 34 | 10 | ||
| Distant metastasis | 0.082 | 0.089 | |||||
| Present | 89 | 54 | 35 | 56 | 33 | ||
| Absent | 6 | 6 | 0 | 6 | 0 | ||
| Tumor size | 0.513 | 0.325 | |||||
| < 3 cm | 34 | 20 | 14 | 20 | 14 | ||
| > 3 cm | 61 | 40 | 21 | 42 | 19 | ||
| Histology | 0.206 | 0.730 | |||||
| Adenocarcinoma | 50 | 34 | 16 | 33 | 17 | ||
| Squamous cell carcinoma | 40 | 22 | 18 | 25 | 15 | ||
| Differentiation | 0.721 | 0.061 | |||||
| Poorly | 9 | 5 | 4 | 3 | 6 | ||
| Moderately, Well | 86 | 55 | 31 | 59 | 27 | ||
| Location | 0.251 | 0.413 | |||||
| Central | 37 | 26 | 11 | 26 | 11 | ||
| Peripheral | 58 | 34 | 24 | 36 | 22 | ||
| Gender | 0.530 | 0.748 | |||||
| Male | 79 | 51 | 28 | 51 | 28 | ||
| Female | 16 | 9 | 7 | 11 | 5 | ||
| Age (years) | 0.606 | 0.064 | |||||
| < 60 | 44 | 29 | 15 | 33 | 11 | ||
| > 60 | 51 | 31 | 20 | 29 | 22 | ||
| Smoking | 0.385 | 0.429 | |||||
| Non-smoker | 38 | 22 | 16 | 23 | 15 | ||
| Smoker | 57 | 38 | 19 | 39 | 18 | ||